BioClinica. Global clinical trial solutions. Real-world results.

Clinical trials are an expensive but essential part of a sponsor's existence. Unless the articles are being tested in the most efficient (yet still safe and complete) way possible, costs of development can rapidly become excessive and needlessly increased. Because testing must include multiple phases and comply with many strict regulations (which also vary among countries), it is essential that companies efficiently organize and manage their trials. With the recent disclosures about problems with drugs on the market (such as Vioxx) and calls for investigation into others, sponsors now, more than ever, must be extremely vigilant in the eyes of both the regulatory bodies and the general public.

Please complete the form to download this white paper.